Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Remifentanil for Controlled Hypotension in Septorhinoplasty
NCT06138574Unknown
- Sponsor
- Gazi Yaşargil Training and Research Hospital
- Start
- Dec 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
01
Overview
Randomised trial of dexmedetomidine in deviated nasal septum (2 arms), sponsored by Gazi Yaşargil Training and Research Hospital. Primary endpoint: Index of Cardiac Electrophysiological Balance. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
deviated nasal septum
Beyond the preview
Go deeper on NCT06138574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06138574.